Literature DB >> 2683026

A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs.

F L Lanza1.   

Abstract

Studies in normal volunteers from our laboratory and by other investigators have demonstrated that non-steroidal anti-inflammatory agents (NSAIDs) can significantly damage the gastroduodenal mucosa. This damage is maximal with plain and buffered aspirin products. The injury produced by non-aspirin NSAIDs in anti-inflammatory doses is less than with aspirin but depends primarily on the dosages used. Pro-drugs and enteric-coated aspirin tend to produce less injury. The incidence of gastric ulcer in 1064 normal volunteers studied in our laboratory over a period of 7 years is reviewed. Seventy-two (6.7%) normal subjects developed a gastric ulcer after 7 days of therapy with anti-inflammatory doses of these drugs. The largest number of ulcers were seen with plain and buffered aspirin, and the lowest number with the lower anti-inflammatory doses of the non-aspirin NSAIDs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2683026     DOI: 10.3109/00365528909091171

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  24 in total

Review 1.  [Non-opioid analgesics for perioperative pain therapy. Risks and rational basis for use].

Authors:  A Brack; H L Rittner; M Schäfer
Journal:  Anaesthesist       Date:  2004-03       Impact factor: 1.041

2.  Molecular modeling study on chemically diverse series of cyclooxygenase-2 selective inhibitors: generation of predictive pharmacophore model using catalyst.

Authors:  Madhu Chopra; Ruby Gupta; Swati Gupta; Daman Saluja
Journal:  J Mol Model       Date:  2008-07-30       Impact factor: 1.810

Review 3.  Newer, safer nonsteroidal anti-inflammatory drugs. Rational NSAID selection for arthritis.

Authors:  W Bensen; A Zizzo
Journal:  Can Fam Physician       Date:  1998-01       Impact factor: 3.275

4.  Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan.

Authors:  Fu-Wei Wang; Ming-Shium Tu; Guang-Yuan Mar; Hung-Yi Chuang; Hsien-Chung Yu; Lung-Chih Cheng; Ping-I Hsu
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

5.  Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding.

Authors:  C M Wilcox; L N Alexander; G A Cotsonis; W S Clark
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

6.  Intestinal permeability and inflammation in patients on NSAIDs.

Authors:  G Sigthorsson; J Tibble; J Hayllar; I Menzies; A Macpherson; R Moots; D Scott; M J Gumpel; I Bjarnason
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

Review 7.  Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach.

Authors:  F Richy; O Bruyere; O Ethgen; V Rabenda; G Bouvenot; M Audran; G Herrero-Beaumont; A Moore; R Eliakim; M Haim; J-Y Reginster
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

8.  Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori.

Authors:  A S Taha; R D Sturrock; R I Russell
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

9.  Nonsteroidal antiinflammatory drugs and upper gastrointestinal hemorrhage in an urban hospital.

Authors:  W A Klein; B Krevsky; L Klepper; P Ljubich; T J Niewiarowski; K D Rothstein; M A Dabezies; R S Fisher
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

Review 10.  Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.

Authors:  Thomas Hedner; Ola Samulesson; Peter Währborg; Hans Wadenvik; Kjell-Arne Ung; Anders Ekbom
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.